Health news today centers on how care is changing at both ends of the system: health authorities are trying to contain long-term threats like drug resistance and cancer risk, while new medicines and online health trends are reshaping what patients can access. The mix is one of in...
Health news today centers on how care is changing at both ends of the system: health authorities are trying to contain long-term threats like drug resistance and cancer risk, while new medicines and online health trends are reshaping what patients can access. The mix is one of innovation and warning, with faster tests and new treatments arriving alongside concerns about misuse, dependence and misinformation.
The World Health Organization warns that progress against antimicrobial resistance is still falling short of global goals, even as more countries step up surveillance and response efforts. Officials say drug-resistant infections continue to spread and threaten routine treatment, surgery and cancer care, underscoring the risk that common antibiotics are becoming less effective.
The NHS in England is moving to roll out a seven-minute “sponge on a string” test to identify people at higher risk of oesophageal cancer. The minimally invasive test is designed to widen earlier detection outside more burdensome hospital procedures and could help find disease sooner in patients with warning signs or known risk factors.
Boots is launching an online service, SureLeaf, that will prescribe medical cannabis to eligible patients in the UK. The offer is being presented as a first for a major British high street pharmacy, with access limited to adults aged 25 and over who meet criteria for approved conditions.
Dr. John H. Powers III is appointed permanent director of the U.S. National Institute of Allergy and Infectious Diseases after serving in the role on an acting basis. He now takes charge of one of the country’s most prominent infectious-disease research institutes at a time of continued focus on preparedness, vaccines and emerging threats.
A Chinese weight-loss injection called ribupatide posts strong results in a clinical trial, with participants reported to lose close to a fifth of their body weight over 11 months. The drug adds to the fast-growing obesity treatment market, and trials in the UK are also under way as interest in next-generation medicines expands.
Doctors are warning teenagers against using the cancer drug erdafitinib to try to grow taller as a social-media-driven “heightmaxxing” trend spreads online. The medicine is being promoted in forums and videos with advice on sourcing and dosage, despite the risk of serious side effects from taking a potent cancer treatment without medical need.
A pharmacist is urging people with diabetes not to stop taking metformin after a warning about the drug circulates on TikTok. The message aims to prevent patients from making abrupt changes to a common treatment without medical advice, reflecting wider concern about health misinformation spreading on social media.
A New Zealand inquiry finds that failures at Whanganui Hospital delayed a woman’s endometrial cancer diagnosis by about a year, leaving the disease undetected until it was advanced. The Health and Disability Commissioner identifies a series of systemic problems in her care, turning the case into a broader warning about diagnostic safety and follow-up.
A woman describes becoming dependent on kratom after her use escalates from four capsules a day to as many as 100. She says the growing intake left her feeling trapped and disconnected before she sought help, highlighting concerns about addiction risks linked to a substance that some users treat as a wellness aid or pain remedy.
Singapore’s Communicable Diseases Agency is designated a WHO collaborating centre for infection prevention and control. The move gives formal international recognition to the agency’s role in helping strengthen outbreak preparedness, clinical standards and disease-response capacity as governments continue building public-health defenses after recent global epidemics.






Top Health stories
- Boots to launch SureLeaf service prescribing medical cannabis for eligible UK patients (6 sources)
- Teenagers use cancer drug erdafitinib for height, prompting warnings of serious health risks (4 sources)
- NEET PG 2026 Round 2 provisional seat allotment results date announced (3 sources)
- Kay Lake Loses Nearly 200 Pounds Ahead of Daughter’s Wedding Photos (3 sources)
- John H. Powers III appointed permanent director of NIAID (3 sources)
- Australia’s top medical body issues interim guidance on puberty blockers for trans youth (2 sources)
- Chinese weight-loss drug ribupatide shows significant trial weight loss (2 sources)
- Australia’s medical body advises conditional puberty blocker use for children amid state bans (2 sources)
Heather Headlines
Author at IfHighLow